F 461 (F-461)

RN & NM refer to HCl

Also Known As:

F-461; 3-diethylamino-2,2-dimethylpropyl 5-(p-nitrophenyl)-2-furoate hydrochloride; 5-(4-nitrophenyl)-2-furancarboxylic acid, 3-(diethylamino)-2,2-dimethylpropyl ester, monohydrochloride

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Furans: 85
    - F 461: 1

Related Diseases

1.	Peptic Ulcer (Peptic Ulcers) 07/01/1976 - "The pharmacologic properties of F-461, as revealed in this study, are indicative of potential usefulness of this drug in the therapy of spastic colon and/or peptic ulcers."
2.	Muscle Spasticity (Spastic) 07/01/1976 - "The pharmacologic properties of F-461, as revealed in this study, are indicative of potential usefulness of this drug in the therapy of spastic colon and/or peptic ulcers."
3.	Ulcer 07/01/1976 - "F-461 was additionally discovered to inhibit gastric acid secretion and to prevent cold + restraint stress-induced ulcers. "

Related Therapies and Procedures

1.	Therapeutics